City

Clermont-Ferrand (1)

Lyon (1)

Marseille (1)

Montpellier (1)

Orange (1)

Pessac (1)

Pierre-Benite (1)

Strasbourg (1)

Toulouse (1)

Condition

CLL, Refractory (2)

CLL, Relapsed (2)

AML, Adult (1)

Acute Myeloid Leukemia (1)

Bruton Tyrosine Kinase Inhibitor (1)

CLL (1)

Chronic Lymphocytic Leukemia (1)

Small Lymphocytic Leukemia (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

French Innovative Leukemia Organisation (1)

University of California, Irvine (1)

Collaborator

Bristol-Myers Squibb (1)

United States Department of Defense (1)

Intervention

pitavastatin (1)

venetoclax (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

cll, refractory

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy

Not yet recruiting

CLL, Relapsed
+3 more

Clermont-Ferrand, France
+7 more

Nov 16, 2022

Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, AML, Adult Trial in Orange (Pitavastatin, Venetoclax)

Recruiting

Acute Myeloid Leukemia
+5 more

Orange, California

Chao Family Comprehensive Cancer Center, University of Californi

Mar 25, 2021